Patient
SITE013-0257
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE013 (USA) (Dr. Clarke)
consented 2026-06-28
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-03-12 (study day 64); relationship: RELATED
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-03-03 (study day 55); relationship: not assessed
Grade 3 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 23); relationship: not assessed; serious criteria: hospitalization
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-26 (study day 19); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-01-21 (study day 14); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.